Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 884.44K P/E - EPS this Y - Ern Qtrly Grth -
Income -4.64M Forward P/E - EPS next Y - 50D Avg Chg -
Sales 715.22k PEG - EPS past 5Y - 200D Avg Chg -74.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -93.00%
Recommedations - Quick Ratio 0.01 Shares Outstanding 77.69M 52W Low Chg 35.00%
Insider Own 1.11% ROA -193.44% Shares Float 76.58M Beta 1.06
Inst Own - ROE - Shares Shorted/Prior -/- Price 0.01
Gross Margin 42.70% Profit Margin - Avg. Volume 1,534 Target Price -
Oper. Margin -1,047.35% Earnings Date May 10 Volume 20,000 Change 0.00%
About AVIVAGEN INC

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.